NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1427017441 MD
Verify on CMS → Vanessa Rodriguez, MD
Endocrinology, Diabetes & Metabolism Physician in Delray Beach, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 317 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
41%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
21.3/100
▼ 62 pts below national avg 83.5 · Below average
Industry payments
$150.32
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Vanessa Rodriguez, MD reported a CMS MIPS final score of 21.3/100 - below the 83.5 national average - and filed 1,935 Medicare Part D claims in 2023.
- 21.3/100
- MIPS score · -62 vs avg
- 2K
- Part D claims, 2023
- 41%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1427017441 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1427017441
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-LOW 21.3/100
- RX-MID 1,935
- BOOK-LIGHT 519 in Florida
- PHOTO-FINISH Victoria Finn · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Leonard Gioia · …
Leonard Gioia
21.2 MIPS pts
- Rodriguez · this…
Rodriguez · this provider
21.3 MIPS pts
- Victoria Finn · …
Victoria Finn
21.3 MIPS pts
- Susan Henley · n…
Susan Henley
21.3 MIPS pts
- Michael Santulli…
Michael Santulli
21.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Vanessa Rodriguez, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
21 ≥ 3rd percentile 3% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Vanessa Rodriguez, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Vanessa Rodriguez, MD writes more Part D claims than 44% of them and scores higher on MIPS quality than 4% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Vanessa Rodriguez, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Vanessa Rodriguez, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Vanessa Rodriguez, MD?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,935 27% vs specialty avg
MIPS final score
21.3/100 62.2 pts vs avg
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Vanessa Rodriguez, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 21.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1427017441 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/20/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
21.3295
Final Score
Measured-score avg: 83.5
0
Quality
71.0983
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Vanessa Rodriguez, MD. Source: openpaymentsdata.cms.gov.
Total received
$150
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Vanessa Rodriguez, MD. To verify Vanessa Rodriguez, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Vanessa Rodriguez, MD - brand share 52.0%
Endocrinology, Diabetes & Metabolism Physician average
52% brand-name claims vs 41% generic, on 1,935 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,935
Total Claims
$1.0M
Total Drug Cost
317
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,087
- Total Day Supply
- 151,788
- Brand vs Generic
- 52% brand / 41% generic
- Brand Drug Cost
- $952K
- Generic Drug Cost
- $23K
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.75
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 15, 65-74: 146, 75-84: 129, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Vanessa Rodriguez, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metformin Hcl Er
Metformin Hcl Er
164 claims
- Ozempic
Ozempic
131 claims
- Synthroid
Synthroid
129 claims
- Unithroid
Unithroid
111 claims
- Levoxyl
Levoxyl
94 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
85 claims
- Metformin Hcl
Metformin Hcl
68 claims
- Atorvastatin Calcium 62
Atorvastatin Calcium
62 claims
| Drug | Claims |
|---|---|
| Metformin Hcl Er Metformin Hcl | 164 |
| Ozempic Semaglutide | 131 |
| Synthroid Levothyroxine Sodium | 129 |
| Unithroid Levothyroxine Sodium | 111 |
| Levoxyl Levothyroxine Sodium | 94 |
| Rosuvastatin Calcium | 85 |
| Metformin Hcl | 68 |
| Atorvastatin Calcium | 62 |
| Jardiance Empagliflozin | 61 |
| Trulicity Dulaglutide | 47 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Vanessa Rodriguez, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Vanessa Rodriguez, MD's 1,935 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rodriguez, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (21.3 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Rodriguez.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Vanessa Rodriguez, MD's specialty? ▼
Vanessa Rodriguez, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Delray Beach, Florida. Credentials: MD.
How much does Vanessa Rodriguez, MD prescribe under Medicare Part D? ▼
In 2023, Vanessa Rodriguez, MD wrote 1,935 Medicare Part D claims totaling $1.0M in drug costs for 317 beneficiaries.
What is Vanessa Rodriguez, MD's Medicare quality score? ▼
Vanessa Rodriguez, MD has a CMS MIPS Final Score of 21.3/100 (Quality: 0, Cost: 71.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Vanessa Rodriguez, MD located? ▼
Vanessa Rodriguez, MD is located at 550 SE 6TH AVE # 200X, Delray Beach, FL, 33483. Phone: (561) 600-2408.
What is Vanessa Rodriguez, MD's NPI number? ▼
Vanessa Rodriguez, MD's National Provider Identifier (NPI) is 1427017441, issued on 03/20/2006.
Does Vanessa Rodriguez, MD prescribe more brand-name or generic drugs? ▼
Vanessa Rodriguez, MD's prescribing is 52% brand-name and 41% generic drugs by claim count, with $952K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Vanessa Rodriguez, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Vanessa Rodriguez, MD's most frequently prescribed drugs include Metformin Hcl Er, Ozempic, Synthroid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Vanessa Rodriguez, MD accept Medicare? ▼
Vanessa Rodriguez, MD appears in CMS Medicare data with 1,935 Part D claims and 317 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Vanessa Rodriguez, MD's credentials? ▼
Vanessa Rodriguez, MD's NPI is 1427017441 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.